- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06898866
Functional and Occupational Rehabilitation of Troops (FORT)
January 15, 2026 updated by: The University of Texas Health Science Center at San Antonio
An Effectiveness-Implementation Trial of Functional Restoration for Chronic Pain Management in Active Duty Military Personnel
The proposed implementation science project will evaluate the factors that support or hinder the successful implementation of the FORT Functional Restoration Program at six Military Treatment Facilities (MTF) across the Military Health System.
It will also evaluate the associated effectiveness outcomes related to chronic musculoskeletal pain management in active-duty military personnel.
Study Overview
Status
Not yet recruiting
Conditions
Detailed Description
This project will be an effectiveness-implementation hybrid type 2 study design using a stepped-wedge randomized clinical trial research design.
The study will simultaneously evaluate clinical and implementation outcomes related to the establishment of functional restoration programs.
The study investigators have collaborated with the Defense Health Agency (DHA) Pain Management Clinical Support Services to identify chronic pain management programs at six MTFs interested in systematically improving and assessing the outcomes of their program.
The MTFs will be randomized in pairs to initiate the Implementation Facilitation strategy to improve the implementation of their program over three 6-month intervals, after an initial 6-month baseline.
This hybrid design will allow for the evaluation of both implementation and clinical effectiveness research aims and support rapid translation of research outcomes.
Each site will participate in a minimum 6-month baseline period prior to the intervention period to serve as its own treatment as usual.
Study Type
Observational
Enrollment (Estimated)
480
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Alan L Peterson, PhD
- Phone Number: 210.562.6700
- Email: Petersona3@uthscsa.edu
Study Contact Backup
- Name: Katherine A Comtois, PhD, MPH
- Phone Number: 206-744-1752
- Email: kcomtois@uw.edu
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Active duty military personnel diagnosed with chronic musculoskeletal pain.
Description
Inclusion Criteria:
"patient referred to functional restoration program by provider"
Exclusion Criteria:
"patient not referred to functional restoration program by provider"
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Treatment as Usual
At their assigned step, each site will receive 6 months of Treatment as Usual (TAU).
This step will include patients seen at each of the six study sites who participate in the current interdisciplinary chronic pain management program that is available at those sites prior to the initiation of the FORT Implementation Facilitation.
|
|
Implementation Facilitation + FORT
At their assigned step, each site will receive 6 months of External Facilitation kicked off with an initial site visit.
At the site visit, the external facilitators will meet with key stakeholders, clinic providers, and staff.
Together, the team will review the FORT Implementation Site-Assessment Survey as a baseline assessment of implementation as well as the FORT Program Implementation Planning Guide.
The team will work together to develop a site-specific implementation blueprint called the Site Action Plan.
|
|
FORT Functional Restoration
During the subsequent 6 months, the site action plan will be executed, monitored, and refined to meet the implementation goals.
As per Implementation Facilitation, the facilitator will apply many different implementation strategies to support the uptake of FORT, tailoring strategies to the needs of the site and the stakeholders engaged in the process.
Implementation Facilitation will be conducted virtually through a combination of scheduled video teleconferences or phone calls.
Regular implementation team meetings will be scheduled to support the implementation process
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain Impact Score (PIS)
Time Frame: Baseline to 13 months
|
The Pain Impact Score (PIS) is based on the Defense and Veterans Pain Rating Scale (DVPRS), which measures 7-day average pain intensity (0-10 scale) and adaptive PROMIS pain interference and physical function using numeric, color, facial, and word descriptors and is validated.
PROMIS T-scores are converted to compute the PIS, ranging from 8-50 with a higher score indicating greater pain.
|
Baseline to 13 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
June 1, 2026
Primary Completion (Estimated)
January 1, 2028
Study Completion (Estimated)
January 1, 2028
Study Registration Dates
First Submitted
March 18, 2025
First Submitted That Met QC Criteria
March 25, 2025
First Posted (Actual)
March 27, 2025
Study Record Updates
Last Update Posted (Actual)
January 20, 2026
Last Update Submitted That Met QC Criteria
January 15, 2026
Last Verified
January 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY00001264
- W81XWH-22-2-0041 (Other Grant/Funding Number: Department of Defense)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.